Contract Research Organization Services (CROs) Market by Type (Discovery, CMC, Preclinical, Clinical Research, Laboratory Services), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceuticals & Medical Device) - Global Forecast to 2025

Table of Contents

1.... INTRODUCTION

1.1            OBJECTIVES OF THE STUDY
1.2            MARKET DEFINITION
1.2.1             MARKETS COVERED.. 22
1.2.2             YEARS CONSIDERED FOR THE STUDY
1.3            CURRENCY
1.4            STAKEHOLDERS

2.... RESEARCH METHODOLOGY

2.1            RESEARCH DATA
2.1.1             SECONDARY SOURCES. 26
2.1.1.1           KEY DATA FROM SECONDARY SOURCES
2.1.2             PRIMARY DATA
2.1.2.1           KEY DATA FROM PRIMARY SOURCES
2.2            MARKET SIZE ESTIMATION
2.2.1             REVENUE SHARE ANALYSIS
2.2.2             ILLUSTRATION OF COMPANY REVENUE ANALYSIS
2.3            MARKET BREAKDOWN AND DATA TRIANGULATION
2.4            MARKET SHARE ESTIMATION
2.5            ASSUMPTIONS FOR THE STUDY

3.... EXECUTIVE SUMMARY

4.... PREMIUM INSIGHTS

4.1            CRO SERVICES MARKET OVERVIEW
4.2            ASIA PACIFIC: CRO SERVICES MARKET, BY TYPE AND COUNTRY
4.3            CRO SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4            CRO SERVICES MARKET: GEOGRAPHIC MIX
4.5            CRO SERVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES

5.... MARKET OVERVIEW

5.1            INTRODUCTION
5.2            MARKET DYNAMICS
5.2.1             DRIVERS
5.2.1.1           GROWTH IN R&D SPENDING
5.2.1.2           INCREASING NUMBER OF CLINICAL TRIALS
5.2.1.3           HIGH COST OF IN-HOUSE DRUG DEVELOPMENT
5.2.1.4           RISING PREVALENCE OF ORPHAN AND RARE DISEASES

5.2.2             OPPORTUNITIES
5.2.2.1           GROWTH IN THE BIOSIMILARS AND BIOLOGICS MARKETS
5.2.2.2           RISING DEMAND FOR SPECIALIZED TESTING SERVICES
5.2.2.3           INCREASING OUTSOURCING ACTIVITIES TO EMERGING ASIAN ECONOMIES
5.2.3             CHALLENGES
5.2.3.1           SHORTAGE OF SKILLED PROFESSIONALS
5.2.4             TRENDS
5.2.4.1           REVOLUTIONARY SHIFT IN THE CRO SERVICES MARKET DUE TO THE GROWING ADOPTION OF ARTIFICIAL INTELLIGENCE-BASED TOOLS FOR DRUG DISCOVERY

6.... CRO SERVICES MARKET, BY TYPE

6.1            INTRODUCTION
6.2            CLINICAL RESEARCH SERVICES
6.2.1             PHASE III CLINICAL RESEARCH SERVICES
6.2.1.1           PHASE III CLINICAL SERVICES ARE THE MOST EXPENSIVE WITH SEVERAL THOUSAND PATIENTS BEING RECRUITED FOR EACH STUDY
6.2.2             PHASE II CLINICAL RESEARCH SERVICES
6.2.2.1           PHASE II CLINICAL STUDIES CAN LAST UP TO TWO YEARS AND PROVIDE AN INDICATION ON THE CLINICAL EFFICACY OF A DRUG OR A DEVICE
6.2.3             PHASE IV CLINICAL RESEARCH SERVICES
6.2.3.1           PHASE IV CLINICAL STUDIES ARE USUALLY CONDUCTED POST-MARKETING OF DRUGS TO EVALUATE ADVERSE DRUG REACTIONS
6.2.4             PHASE I CLINICAL RESEARCH SERVICES
6.2.4.1           PHASE I CLINICAL STUDIES USUALLY PROVIDE AN INDICATION ON MAXIMUM TOLERATED DOSE OF A NEW TREATMENT
6.3            EARLY-PHASE DEVELOPMENT SERVICES
6.3.1             CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES
6.3.1.1           CMC SERVICES INCLUDE A HOST OF TESTING SUCH AS API/PRODUCT RELEASE, STABILITY, AND DISSOLUTION
6.3.2             PRECLINICAL SERVICES
6.3.2.1 PHARMACOKINETICS/PHARMACODYNAMICS
6.3.2.1.1           PK/PD SERVICES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE PRECLINICAL SERVICES MARKET
6.3.2.2           TOXICOLOGY TESTING SERVICES
6.3.2.2.1           TOXICOLOGY TESTING IS CRUCIAL IN CHECKING AND CONFIRMING THE QUALITY, EFFICACY, AND SAFETY OF NEW DRUG SUBSTANCES
6.3.2.3           OTHER PRECLINICAL SERVICES
6.3.3             DISCOVERY STUDIES. 71
6.3.3.1           GROWING NUMBER OF RARE DISEASES TO PROMOTE THE GROWTH OF THIS SEGMENT
6.4            LABORATORY SERVICES
6.4.1             BIOANALYTICAL TESTING SERVICES
6.4.1.1           BIOANALYTICAL TESTING SERVICES ARE REQUIRED TO ESTABLISH THE SAFETY AND EFFICACY OF COMPLEX LARGE MOLECULES

6.4.2             ANALYTICAL TESTING SERVICES
6.4.2.1           PHYSICAL CHARACTERIZATION SERVICES
6.4.2.1.1           INCREASING USE OF NANOPARTICLES IS DRIVING THE NEED FOR PHYSICAL CHARACTERIZATION STUDIES
6.4.2.2           RAW MATERIAL TESTING SERVICES
6.4.2.2.1           THESE SERVICES ARE PERFORMED FROM THE EARLY STAGES OF PRODUCT DEVELOPMENT TO THE COMMERCIAL BATCH-RELEASE STAGES
6.4.2.3           BATCH-RELEASE TESTING SERVICES
6.4.2.3.1           BATCH-RELEASE TESTING SERVICES INCLUDE DISINTEGRATION, DISSOLUTION, HARDNESS, AND ELEMENTAL IMPURITIES TESTING
6.4.2.4           STABILITY TESTING SERVICES
6.4.2.4.1           STABILITY TESTING STUDIES ENSURE THE QUALITY, SAFETY, AND EFFICACY OF A PHARMACEUTICAL PRODUCT THROUGHOUT ITS SHELF LIFE
6.4.2.5           OTHER ANALYTICAL TESTING SERVICES
6.5            CONSULTING SERVICES
6.5.1             CONSULTING SERVICES ARE UTILIZED FOR DRUG DEVELOPMENT AND REGULATORY STRATEGIES
6.6            DATA MANAGEMENT SERVICES
6.6.1             DATA MANAGEMENT SERVICES ARE EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD

7.... CRO SERVICES MARKET, BY THERAPEUTIC AREA

7.1            INTRODUCTION
7.2            ONCOLOGY
7.2.1             INCREASING NUMBER OF CANCER CASES DRIVING THE GROWTH OF THIS SEGMENT
7.3            CENTRAL NERVOUS SYSTEM DISORDERS
7.3.1             INCREASING AWARENESS RELATED TO NEUROLOGICAL DISORDERS DRIVING RESEARCH IN THIS AREA
7.4            INFECTIOUS DISEASES
7.4.1             INCREASING EPIDEMIC OUTBREAKS CALLING FOR INCREASING DRUG DISCOVERY ACTIVITIES RELATED TO INFECTIOUS DISEASES
7.5            CARDIOVASCULAR SYSTEM DISORDERS
7.5.1             HIGH CVS DISORDER-RELATED MORTALITY IS DRIVING PHARMACEUTICAL COMPANIES TO DEVELOP NEW TREATMENT OPTIONS
7.6            METABOLIC DISORDERS
7.6.1             GROWING GLOBAL DIABETES POPULATION IS EXPECTED TO DRIVE MARKET GROWTH
7.7            IMMUNOLOGICAL DISORDERS
7.7.1             GROWING IMMUNOLOGICAL DRUGS PIPELINE IS RESULTING IN AN INCREASE IN OUTSOURCING ACTIVITIES
7.8            RESPIRATORY DISORDERS
7.8.1             COPD IS ONE OF THE MAJOR CAUSES OF DEATHS GLOBALLY

7.9            OPHTHALMOLOGY DISORDERS
7.9.1             RETINA, GLAUCOMA, AND MACULAR DEGENERATION TRIALS DOMINATE OPHTHALMOLOGY RELATED CLINICAL TRIALS
7.10          OTHER THERAPEUTIC AREAS

8.... CRO SERVICES MARKET, BY END USER

8.1            INTRODUCTION
8.2            PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
8.2.1             INCREASING R&D EXPENDITURE AND ROBUST PIPELINE TO DRIVE MARKET GROWTH
8.3            MEDICAL DEVICE COMPANIES
8.3.1             INCREASE IN R&D FOR DEVELOPMENT OF ADVANCED MEDICAL DEVICES IS FUELING MARKET GROWTH
8.4            ACADEMIC INSTITUTES
8.4.1             ACADEMIA-INDUSTRY COLLABORATIONS PROVIDE MORE FLEXIBLE AND EFFICIENT PATHWAYS FOR CLINICAL DEVELOPMENT

9.... CRO SERVICES MARKET, BY REGION

9.1            INTRODUCTION
9.2            NORTH AMERICA
9.2.1             US
9.2.1.1           US IS THE LARGEST MARKET FOR CRO SERVICES IN NORTH AMERICA
9.2.2             CANADA
9.2.2.1           INCREASING NUMBER OF CLINICAL TRIALS IN CANADA TO SUPPORT MARKET GROWTH
9.3            EUROPE
9.3.1             GERMANY
9.3.1.1           GOVERNMENT SUPPORT AND FLEXIBLE LABOR LAWS HAVE MADE GERMANY A FAVORABLE LOCATION FOR CLINICAL TRIALS
9.3.2             UK
9.3.2.1           INVESTMENT BY PHARMACEUTICAL SPONSORS IN THE UK FOR DRUG DISCOVERY SERVICES TO SUPPORT MARKET GROWTH
9.3.3             FRANCE
9.3.3.1           HIGH NUMBER OF ONCOLOGY CLINICAL TRIALS IN FRANCE TO DRIVE MARKET GROWTH
9.3.4             ITALY
9.3.4.1           LOW DRUG APPROVAL TIME IN ITALY, ALONG WITH THE GROWING NUMBER OF CLINICAL TRIALS, TO DRIVE MARKET GROWTH
9.3.5             SPAIN
9.3.5.1           SHORT STUDY START-UP TIMES AND RISING R&D EXPENDITURE TO BOOST THE GROWTH OF THE SPANISH MARKET
9.3.6             REST OF EUROPE
9.4            ASIA PACIFIC
9.4.1             CHINA
9.4.1.1           CHINA DOMINATED THE CRO SERVICES MARKET IN THE ASIA PACIFIC
9.4.2             JAPAN
9.4.2.1           RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH IN JAPAN
9.4.3             INDIA
9.4.3.1           GROWING PHARMACEUTICAL INDUSTRY IN INDIA TO DRIVE MARKET GROWTH. 167
9.4.4             AUSTRALIA
9.4.4.1           AUSTRALIA IS A FAVORABLE LOCATION FOR DRUG DISCOVERY DUE TO A LARGE NUMBER OF RESEARCH INSTITUTES IN THE COUNTRY
9.4.5             SOUTH KOREA
9.4.5.1           GROWING R&D EXPENDITURE IN SOUTH KOREA TO DRIVE MARKET GROWTH
9.4.6             REST OF ASIA PACIFIC
9.5            LATIN AMERICA
9.5.1             GROWING R&D EXPENDITURE IN THE PHARMACEUTICAL AND BIOPHARMACEUTICAL SECTOR TO DRIVE MARKET GROWTH IN LATIN AMERICA
9.6            MIDDLE EAST & AFRICA
9.6.1             GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH IN THE MIDDLE EAST AND AFRICA

10.. COMPETITIVE LANDSCAPE

10.1          OVERVIEW
10.2          MARKET SHARE ANALYSIS: CRO SERVICES MARKET (2019)
10.3          COMPETITIVE LEADERSHIP MAPPING
10.3.1           VISIONARY LEADERS
10.3.2           INNOVATORS
10.3.3           DYNAMIC DIFFERENTIATORS
10.3.4           EMERGING COMPANIES
10.4          COMPETITIVE SITUATION AND TRENDS
10.4.1           SERVICE LAUNCHES
10.4.2           EXPANSIONS
10.4.3           ACQUISITIONS
10.4.4           PARTNERSHIPS & AGREEMENTS

11.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW, STRATEGIC OVERVIEW)*
11.1          IQVIA
11.2          LABCORP
11.3          SYNEOS HEALTH INC. 208
11.4          WUXI APPTEC
11.5          CHARLES RIVER LABORATORIES
11.6          PAREXEL INTERNATIONAL
11.7          PRA HEALTH SCIENCES
11.8          PPD
11.9          ICON PLC
11.10        MEDPACE HOLDINGS
11.11        SGS
11.12        PSI CRO AG
11.13        AXCENT ADVANCED ANALYTICS
11.14        BIOAGILE THERAPEUTICS
11.15        FIRMA CLINICAL RESEARCH
11.16        ACCULAB LIFESCIENCES
11.17        AZELIX
11.18        CTSERV
11.19        PEPGRA
11.20        DOVE QUALITY SOLUTIONS
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW STRATEGIC OVERVIEW, MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

12.. APPENDIX

LIST OF TABLES

TABLE 1              RESEARCH PROJECTS FUNDED BY THE INTERNATIONAL RARE DISEASES RESEARCH CONSORTIUM, 2019
TABLE 2              LIST OF BIOLOGICAL LICENSE APPLICATION APPROVALS IN THE US, 2019
TABLE 3              CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 4              CRO SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 5              NUMBER OF REGISTERED AND RECRUITING CLINICAL STUDIES AS OF MARCH 2020, BY LOCATION
TABLE 6              EXAMPLES OF CLINICAL RESEARCH SERVICES OFFERED BY MARKET PLAYERS
TABLE 7              CLINICAL RESEARCH SERVICES MARKET, BY PHASE, 2018–2025 (USD MILLION)
TABLE 8              CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 9              EXAMPLES OF DRUGS THAT COMPLETED PHASE III STUDIES
TABLE 10            PHASE III CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 11            EXAMPLES OF DRUGS THAT COMPLETED PHASE II STUDIES
TABLE 12            PHASE II CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 13            EXAMPLES OF DRUGS THAT COMPLETED PHASE IV CLINICAL STUDIES
TABLE 14            PHASE IV CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 15            EXAMPLES OF DRUGS AND MEDICAL DEVICES THAT COMPLETED PHASE I STUDIES
TABLE 16            PHASE I CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 17            EXAMPLES OF EARLY-PHASE DEVELOPMENT SERVICES OFFERED BY MARKET PLAYERS
TABLE 18            EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 19            EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 20            CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21            PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 22            PRECLINICAL SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23            PHARMACOKINETICS/PHARMACODYNAMICS SERVICES MARKET,
BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24            TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 25            OTHER PRECLINICAL SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 26            DISCOVERY STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27            EXAMPLES OF LABORATORY SERVICES OFFERED BY PROMINENT PLAYERS
TABLE 28            LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 29            LABORATORY SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 30            BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 31            ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 32            ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 33            PHYSICAL CHARACTERIZATION SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 34            RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 35            BATCH-RELEASE TESTING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 36            STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37            OTHER ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 38            EXAMPLES OF CONSULTING SERVICES OFFERED BY PROMINENT PLAYERS
TABLE 39            CONSULTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40            EXAMPLES OF DATA MANAGEMENT SERVICES OFFERED BY PROMINENT PLAYERS
TABLE 41            DATA MANAGEMENT SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 42            GLOBAL NUMBER OF CLINICAL TRIALS IN DIFFERENT THERAPEUTIC AREAS,
2015–2018
TABLE 43            CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 44            LIST OF PIPELINE DRUGS FOR ONCOLOGY (2018)
TABLE 45            CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY,
2018-2025 (USD MILLION)
TABLE 46            LIST OF PIPELINE DRUGS FOR NEUROLOGICAL DISORDERS (2018)
TABLE 47            CRO SERVICES MARKET FOR CENTRAL NERVOUS SYSTEM DISORDERS,
BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 48            CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 49            LIST OF PIPELINE DRUGS FOR CARDIOVASCULAR DISEASES (2018)
TABLE 50            CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS,
BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 51            CRO SERVICES MARKET FOR METABOLIC DISORDERS, BY COUNTRY,
2018-2025 (USD MILLION)
TABLE 52            CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 53            LIST OF PIPELINE DRUGS FOR RESPIRATORY DISEASES (2018)
TABLE 54            CRO SERVICES MARKET FOR RESPIRATORY DISEASES, BY COUNTRY,
2018-2025 (USD MILLION)
TABLE 55            CRO SERVICES MARKET FOR OPHTHALMOLOGY DISORDERS, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 56            CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY,
2018-2025 (USD MILLION)
TABLE 57            CRO SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
TABLE 58            CRO SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 59            CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY,
2018-2025 (USD MILLION)
TABLE 60            CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY,
2018-2025 (USD MILLION)
TABLE 61            CRO SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 62            NORTH AMERICA: CRO SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 63            NORTH AMERICA: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 64            NORTH AMERICA: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 65            NORTH AMERICA: EARLY-PHASE DEVELOPMENT SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
TABLE 66            NORTH AMERICA: PRECLINICAL SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 67            NORTH AMERICA: LABORATORY SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 68            NORTH AMERICA: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 69            NORTH AMERICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 70            NORTH AMERICA: CRO SERVICES MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 71            US: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 72            US: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 73            US: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 74            US: PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 75            US: LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 76            US: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 77            US: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 78            US: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 79            NUMBER OF ACTIVE CLINICAL TRIALS IN CANADA, BY CONDITION (2019)
TABLE 80            CANADA: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 81            CANADA: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 82            CANADA: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 83            CANADA: PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84            CANADA: LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85            CANADA: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 86            CANADA: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 87            CANADA: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 88            EUROPE: NUMBER OF COMMERCIAL CLINICAL TRIALS STARTED IN 2017,
BY PHASE
TABLE 89            EUROPE: CRO SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 90            EUROPE: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91            EUROPE: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 92            EUROPE: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 93            EUROPE: PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94            EUROPE: LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 95            EUROPE: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 96            EUROPE: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 97            EUROPE: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 98            GERMANY: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99            GERMANY: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 100          GERMANY: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 101          GERMANY: PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 102          GERMANY: LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103          GERMANY: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 104          GERMANY: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 105          GERMANY: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 106          UK: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 107          UK: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 108          UK: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 109          UK: PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 110          UK: LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 111          UK: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 112          UK: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 113          UK: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 114          FRANCE: NUMBER OF COMMERCIAL CLINICAL TRIALS STARTED IN 2017,
BY COMPANY
TABLE 115          FRANCE: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116          FRANCE: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 117          FRANCE: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 118          FRANCE: PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 119          FRANCE: LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 120          FRANCE: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 121          FRANCE: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 122          FRANCE: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 123          NUMBER OF CLINICAL TRIALS STARTED IN ITALY, BY COMPANY (2017)
TABLE 124          ITALY: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 125          ITALY: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 126          ITALY: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 127          ITALY: PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128          ITALY: LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129          ITALY: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 130          ITALY: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 131          ITALY: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 132          SPAIN: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133          SPAIN: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 134          SPAIN: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 135          SPAIN: PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 136          SPAIN: LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 137          SPAIN: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 138          SPAIN: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 139          SPAIN: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 140          ROE: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 141          CLINICAL RESEARCH SERVICES MARKET, BY PHASE, 2018–2025 (USD MILLION)
TABLE 142          ROE: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 143          ROE: PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 144          ROE: LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 145          ROE: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 146          ROE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 147          ROE: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 148          TOTAL NUMBER OF CLINICAL TRIALS IN THE ASIA PACIFIC, BY THERAPEUTIC AREA, 2017 VS. 2019
TABLE 149          ASIA PACIFIC: CRO SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 150          ASIA PACIFIC: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 151          ASIA PACIFIC: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 152          ASIA PACIFIC: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 153          ASIA PACIFIC: PRECLINICAL SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 154          ASIA PACIFIC: LABORATORY SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 155          ASIA PACIFIC: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 156          ASIA PACIFIC: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)

TABLE 157          ASIA PACIFIC: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 158          TOTAL NUMBER OF CLINICAL TRIALS IN CHINA, BY THERAPEUTIC AREA,
2017 VS. 2019
TABLE 159          CHINA: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 160          CHINA: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 161          CHINA: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 162          CHINA: PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 163          CHINA: LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 164          CHINA: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 165          CHINA: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 166          CHINA: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 167          TOTAL NUMBER OF CLINICAL TRIALS IN JAPAN, BY THERAPEUTIC AREA,
2017 VS. 2019
TABLE 168          JAPAN: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 169          JAPAN: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 170          JAPAN: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 171          JAPAN: PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 172          JAPAN: LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 173          JAPAN: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 174          JAPAN: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 175          JAPAN: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 176          TOTAL NUMBER OF CLINICAL TRIALS IN INDIA, BY THERAPEUTIC AREA,
2017 VS. 2019
TABLE 177          INCREASE IN R&D EXPENDITURE OF TOP 5 INDIAN PHARMACEUTICAL COMPANIES (2010 VS. 2018)
TABLE 178          INDIA: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 179          INDIA: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 180          INDIA: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 181          INDIA: PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 182          INDIA: LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 183          INDIA: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 184          INDIA: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 185          INDIA: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 186          AUSTRALIA: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 187          AUSTRALIA: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 188          AUSTRALIA: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 189          AUSTRALIA: PRECLINICAL SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 190          AUSTRALIA: LABORATORY SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 191          AUSTRALIA: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 192          AUSTRALIA: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 193          AUSTRALIA: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 194          SOUTH KOREA: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 195          SOUTH KOREA: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 196          SOUTH KOREA: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY
TYPE, 2018–2025 (USD MILLION)
TABLE 197          SOUTH KOREA: PRECLINICAL SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 198          SOUTH KOREA: LABORATORY SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 199          SOUTH KOREA: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 200          SOUTH KOREA: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 201          SOUTH KOREA: CRO SERVICES MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 202          TOTAL NUMBER OF CLINICAL TRIALS IN SINGAPORE AND MALAYSIA,
BY THERAPEUTIC AREA, 2017 VS. 2019
TABLE 203          ROAPAC: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 204          ROAPAC: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 205          ROAPAC: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2018-2025 (USD MILLION)
TABLE 206          ROAPAC: PRECLINICAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 207          ROAPAC: LABORATORY SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 208          ROAPAC: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 209          ROAPAC: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 210          ROAPAC: CRO SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 211          CLINICAL TRIALS FOR DIFFERENT THERAPEUTIC AREAS IN LATINA AMERICA (2017)
TABLE 212          NUMBER OF CLINICAL TRIALS IN LATINA AMERICA, BY COUNTRY
TABLE 213          LATIN AMERICA: CRO SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 214          LATIN AMERICA: CLINICAL RESEARCH SERVICES MARKET, BY PHASE,
2018–2025 (USD MILLION)
TABLE 215          LATIN AMERICA: EARLY-PHASE DEVELOPMENT SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
TABLE 216          LATIN AMERICA: PRECLINICAL SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 217          LATIN AMERICA: LABORATORY SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 218          LATIN AMERICA: ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 219          LATIN AMERICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION)
TABLE 220          LATIN AMERICA: CRO SERVICES MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 221          CLINICAL TRIALS FOR DIFFERENT THERAPEUTIC AREAS IN MIDDLE EAST
AND AFRICA (2017)
TABLE 222          NUMBER OF CLINICAL TRIALS IN THE MIDDLE EAST AND AFRICA,
BY COUNTRY (2019)
TABLE 223          MIDDLE EAST AND AFRICA: CRO SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 224          MIDDLE EAST AND AFRICA: CLINICAL RESEARCH SERVICES MARKET,
BY PHASE, 2018–2025 (USD MILLION)
TABLE 225          MIDDLE EAST AND AFRICA: EARLY-PHASE DEVELOPMENT SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
TABLE 226          MIDDLE EAST AND AFRICA: PRECLINICAL SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 227          MIDDLE EAST AND AFRICA: LABORATORY SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 228          MIDDLE EAST AND AFRICA: ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
TABLE 229          MIDDLE EAST AND AFRICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 230          MIDDLE EAST AND AFRICA: CRO SERVICES MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 231          SERVICE LAUNCHES, 2017–2020
TABLE 232          EXPANSIONS, 2017–2020
TABLE 233          ACQUISITIONS, 2017–2020
TABLE 234          PARTNERSHIPS & AGREEMENTS, 2017–2020

FIGURE 1            CONTRACT RESEARCH ORGANIZATION SERVICES MARKET
FIGURE 2            RESEARCH DESIGN
FIGURE 3            BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION
FIGURE 4            DATA TRIANGULATION METHODOLOGY
FIGURE 5            CRO SERVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 6            CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2020 VS. 2025 (USD MILLION)
FIGURE 7            CRO SERVICES MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 8            GEOGRAPHIC SNAPSHOT: CRO SERVICES MARKET
FIGURE 9            GROWING R&D EXPENDITURE AND INCREASE IN THE NUMBER OF CLINICAL TRIALS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 10          CHINA DOMINATED THE APAC CRO SERVICES MARKET IN 2019
FIGURE 11          CHINA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
FIGURE 12          NORTH AMERICA TO CONTINUE TO DOMINATE THE CRO SERVICES MARKET DURING THE FORECAST PERIOD
FIGURE 13          DEVELOPING COUNTRIES TO PRESENT HIGH GROWTH OPPORTUNITIES TO MARKET PLAYERS DURING THE FORECAST PERIOD
FIGURE 14          CRO SERVICES MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS
FIGURE 15          INCREASING R&D SPENDING OF PHRMA MEMBER COMPANIES, 2010–2018
FIGURE 16          ACTIVE PHARMACEUTICAL PIPELINE, 2009–2019
FIGURE 17          INCREASING NUMBER OF CLINICAL TRIALS WORLDWIDE (2002–2020)
FIGURE 18          AVERAGE COST TO DEVELOP A PHARMACEUTICAL COMPOUND FROM DISCOVERY TO LAUNCH, 2013–2019 (USD BILLION)
FIGURE 19          TOTAL NUMBER OF NEW BIOLOGIC LICENSE APPLICATION FILINGS, APPROVALS, AND NDA APPROVALS (2005–2019)
FIGURE 20          NUMBER OF CLINICAL TRIALS, 2010–2020
FIGURE 21          DRUGS IN PIPELINE, BY DEVELOPMENT PHASE, 2018 VS. 2019
FIGURE 22          BIOPHARMACEUTICAL DRUGS IN DEVELOPMENT IN THE US, BY THERAPEUTIC AREA (2019)
FIGURE 23          PHASES OF DRUG DISCOVERY STUDIES
FIGURE 24          INCIDENCE OF ALL TYPES OF CANCER CASES WORLDWIDE (2018)
FIGURE 25          TOTAL NUMBER OF CLINICAL TRIALS FOR ONCOLOGY (2017)
FIGURE 26          PREVALENCE OF DIAGNOSED INFECTIOUS DISEASES IN SELECTED COUNTRIES (2019)
FIGURE 27          ESTIMATED NUMBER OF INDIVIDUALS WITH DIABETES FROM
2000 TO 2045 (IN MILLION)
FIGURE 28          ANNUAL DRUG APPROVALS BY CDER (2009–2018)
FIGURE 29          R&D SPENDING OF PHARMA MEMBER COMPANIES, 2011–2018
FIGURE 30          ACTIVE PHARMACEUTICAL PIPELINE, 2009–2019
FIGURE 31          APPROVED NUMBER OF CLINICAL TRIALS WORLDWIDE (2000–2018)
FIGURE 32          R&D SPENDING OF LEADING MEDICAL DEVICE COMPANIES
(IN USD MILLION), 2018
FIGURE 33          CRO SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 34          TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2019)
FIGURE 35          NORTH AMERICA: CRO SERVICES MARKET SNAPSHOT
FIGURE 36          US: PIPELINE SPLIT OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES,
BY PHASE (JANUARY 2019)
FIGURE 37          TOTAL R&D EXPENDITURE OF THE US PHARMACEUTICAL INDUSTRY (2010–2018)
FIGURE 38          UK: PHARMACEUTICAL R&D EXPENDITURE, 2013–2017 (USD MILLION)
FIGURE 39          SPAIN: PHARMACEUTICAL R&D EXPENDITURE, 2011–2017
FIGURE 40          ASIA PACIFIC: CRO SERVICES MARKET SNAPSHOT
FIGURE 41          AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS—KEY GROWTH STRATEGY ADOPTED BY SOME MARKET PLAYERS FROM JANUARY 2017 TO JANUARY 2020
FIGURE 42          CRO SERVICES MARKET SHARE, BY KEY PLAYER, 2019
FIGURE 43          CRO SERVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
FIGURE 44          IQVIA: COMPANY SNAPSHOT (2019)
FIGURE 45          LABCORP: COMPANY SNAPSHOT (2019)
FIGURE 46          SYNEOS HEALTH INC.: COMPANY SNAPSHOT (2019)
FIGURE 47          WUXI APPTEC: COMPANY SNAPSHOT (2018)
FIGURE 48          CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2019)
FIGURE 49          PRA HEALTH SCIENCES: COMPANY SNAPSHOT (2018)
FIGURE 50          ICON: COMPANY SNAPSHOT (2019)
FIGURE 51          MEDPACE HOLDINGS: COMPANY SNAPSHOT (2018)
FIGURE 52          SGS: COMPANY SNAPSHOT (2019)

当レポートのプレスリリースは発行されておりません。